Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial

Martin H Ruwald, Wojciech Zareba, Christian Jons, Claire Zhang, Anne-Christine H Ruwald, Brian Olshansky, Scott McNitt, Poul Erik Bloch Thomsen, Morio Shoda, Bela Merkely, Arthur J Moss, Valentina Kutyifa

    26 Citationer (Scopus)

    Abstract

    The relationship between diabetes mellitus and risk of inappropriate or appropriate therapy in patients receiving an implantable cardioverter-defibrillator (ICD) and resynchronization therapy has not been investigated thoroughly. The effect of innovative ICD programming on therapy delivery in these patients is unknown.
    OriginalsprogEngelsk
    TidsskriftCirculation (Baltimore)
    Vol/bind128
    Udgave nummer7
    Sider (fra-til)694-701
    Antal sider8
    ISSN0009-7322
    DOI
    StatusUdgivet - 13 aug. 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial'. Sammen danner de et unikt fingeraftryk.

    Citationsformater